Catalyst Wire Dossier Catalyst Wire Dossier

Everolimus (generic)

Everolimus · Hikma Pharmaceuticals USA Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Everolimus (generic), covering 2021-11-23 to 2021-11-23. Get the full timeline:

Most recent: FDA Approved: EVEROLIMUS — Original Application (Hikma Pharmaceuticals USA Inc.)

See pricing